Mdm2: the ups and downs
Clicks: 242
ID: 271261
1999
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
7.2
/100
24 views
24 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Mdm2: the ups and downs
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (5 words).
Try re-searching for a better abstract.
| Reference Key |
t1999molecularmdm2:
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Juven-Gershon T;Oren M;; |
| Journal | Molecular medicine (Cambridge, Mass.) |
| Year | 1999 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
Post-Translational
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
non-p.h.s.
P.H.S.
cell differentiation / physiology
proto-oncogene proteins / genetics*
protein processing
nuclear proteins*
zinc fingers
neoplasm proteins / metabolism*
tumor suppressor protein p53 / metabolism
proto-oncogene proteins / metabolism*
proto-oncogene proteins c-mdm2
tumor suppressor protein p53 / genetics
m oren
cell cycle / physiology
pmid:10203572
pmc2230410
t juven-gershon
neoplasm proteins / genetics*
proto-oncogene proteins / drug effects
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.